Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  HCA Healthcare, Inc.    HCA

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

HCA HOLDINGS (HOSPITAL CORPORATION AMERICA) : Ex-dividend day for

share with twitter share with LinkedIn share with facebook
share via e-mail
02/28/2020 EDT

A dividend is removed today from HCA Holdings (Hospital Corporation America)'s share.



© Factset 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on HCA HEALTHCARE, INC.
05/13HCA HEALTHCARE : Awarded 2019 Eisenberg Patient Safety and Quality Award
BU
05/06HCA HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/06HCA HEALTHCARE, INC. : Change in Directors or Principal Officers, Amendments to ..
AQ
04/30HCA HEALTHCARE : Inc. to Participate at May Healthcare Conferences
BU
04/24NOBLE ENERGY, SHAKE SHACK, J.C. PENN : Stocks That Defined the Week
DJ
04/24HCA HEALTHCARE : Joins COVID-19 Convalescent Plasma Study
BU
04/23Surgeries, Other Procedures to Resume -- WSJ
DJ
04/22HCA HEALTHCARE : Correction to HCA Healthcare Earnings Article on Tuesday
DJ
04/22Hospitals Aim to Resume Procedures Postponed by Coronavirus--Update
DJ
04/22HCA HEALTHCARE : Correction to "Hospitals Aim to Resume Procedures Postponed by ..
DJ
More news
Financials (USD)
Sales 2020 48 973 M
EBIT 2020 4 823 M
Net income 2020 1 965 M
Debt 2020 32 242 M
Yield 2020 0,39%
P/E ratio 2020 18,2x
P/E ratio 2021 10,5x
EV / Sales2020 1,41x
EV / Sales2021 1,26x
Capitalization 36 824 M
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 136,48 $
Last Close Price 109,07 $
Spread / Highest target 60,4%
Spread / Average Target 25,1%
Spread / Lowest Target -15,7%
EPS Revisions
Managers
NameTitle
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
Thomas Fearn Frist Chairman
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Jonathan B. Perlin Chief Medical Officer & President-Clinical Service
P. Martin Paslick Chief Information Officer & Senior Vice President
Sector and Competitors